Background: Melanocytes transplant for treatment of vitiligo is a common therapy using different surgical procedures. But there was no interest in repigmentation of grayness of hair in the treated vitiliginous area. Objective: To do melanocytes transplant from donor area into the recipient vitiliginous area with associated gray hair. Patient and Methods: This is a case interventional study was done in Department of Dermatology/Baghdad Teaching Hospital from February 2011-March 2012. Eleven patients were enrolled in this study, six males and five females with vitiligo in association of gray hair. Their ages ranged from 8 - 35 years with a mean ±SD of 20.90 ± 7.006. Melanocytes transplant in patients with vitiligo using needling micrografting technique for twelve patches and direct melanocytes transplant from normal donor area into vitiliginous recipient area by dermabrasion technique for eleven patches. Dressing was applied and patients were seen every two weeks for the first month and monthly for one year. Results: Repigmentation of the vitiliginous area was started after two weeks and was obvious at one month that progressed over time. The repigmentation of hair appeared usually after few months and was obvious after four months and the repigmentation of gray hair was quicker in patients with micrografting technique than those with dermabrasion technique. The mean rate of repigmentation was 18.3% at six months and 37.5% at twelve months in micrografting technique while the mean rate of repigmentation was 9.15% at six months and 18.55 at twelve months in dermabrasion technique. Conclusions: Direct transplant of melanocytes from normal donor area into recipient vitiliginous area with associated white hair is an effective procedure to induce repigmentation of gray hair.
 K. E. Sharquie, S. H. Mehenna, A. A. Naji and H. Al-Azzawi, “Inflammatory Changes in Vitiligo: Stage I and II Depigmentation,” The American Journal of Dermatopathology, Vol. 26, No. 2, 2004, p. 108. doi:10.1097/00000372-200404000-00004
 M. B. Abdel-Naser, S. K. Hann and J. C. Bystryn, “Oral Psoralen with UV-A Therapy Releases Circulating Growth Factors that Stimulates Cell Proliferation,” ARCH Dermatology, Vol. 133, No. 12, 1997, pp. 1530-1533. doi:10.1001/archderm.1997.03890480050007
 R. Falabella, “Surgical Therapies for Vitiligo and Other Leukoderma, Part 1: Minigrafting and Suction Epidermal Grafting,” Dermatologic Therapy, Vol. 14, No. 1, 2001, pp. 7-14. doi:10.1046/j.1529-8019.2001.014001007.x
 M. Ozdemir, O. Cetinkale, R. Wolf, A. Kotogyan, C. Mat, B. Tuzun and Y. Tuzun, “Comparison of Two Surgical Approaches for Treating Vitiligo: A Preliminary Study,” International Journal of Dermatology, Vol. 41, No. 3, 2002, pp. 135-138. doi:10.1046/j.1365-4362.2002.01391.x
 A. M. Kahn and M. J. Cohen, “Treatment by Dermabrasion and Epithelial Sheet Grafting,” Journal of the American Academy of Dermatology, Vol. 33, No. 4, 1995, pp. 646-648. doi:10.1016/0190-9622(95)91287-8
 S. V. Mulekar, “Long-Term Follow-Up Study of 142 Patients with Vitiligo Vulgaris Treated by Autologous, Non-Cultured Melanocyte-Keratinocyte Cell Transplantation,” International Journal of Dermatology, Vol. 44, No. 10, 2005, pp. 841-845. doi:10.1111/j.1365-4632.2005.02226.x
 S. V. Mulekar, A. Al Issa and A. Al Eisa, “Treatment of Vitiligo on Difficult-To-Treat Sites Using Autologous Non-cultured Cellular Grafting,” Dermatological Surgery, Vol. 35, No. 1, 2009, pp. 66-71. doi:10.1111/j.1524-4725.2008.34384.x
 S. V. Mulekar, “Stable Vitiligo Treated by a Combination of Low-Dose Oral Pulse Betamethasone and Autologous, Melanocyte-Keratinocyte Cell Transplantation,” Dermatologic Surgery, Vol. 32, No. 4, 2006, pp. 536-541. doi:10.1111/j.1524-4725.2006.32109.x
 S. V. Mulekar, B. Ghwish, A. Al Issa and A. Al Eisa, “Treatment of Vitiligo Leasions by ReCell vs. Conventional Melanocyte-Keratinocyte Transplantation: Pilot Study,” Journal of the European Academy of Dermatology and Venereology, Vol. 158, No. 1, 2008, pp. 45-49.
 B. M. El-Zawahry, N. S. Zaki, D. A. Bassiouny, R. M. Sobhi, A. Zaghloul, M. M. Khorshied and H. M. Gouda, “Atologous Melanocyte-Keratinocyte Suspension in the Treatment of Vitiligo,” Journal of the European Academy of Dermatology and Venereology, Vol. 25, No. 2, 2011, pp. 215-220. doi:10.1111/j.1468-3083.2010.03759.x
 R. Czajkowski, W. Placer, T. Drewa, B. Kowaliszyn, J. Sir and W. Weiss, “Autologous Cultured Melanocytea in Vitiligo Treatment,” Dermatologic Surgery, Vol. 33, No. 9, 2007, pp. 1027-1036. doi:10.1111/j.1524-4725.2007.33216.x
 K. E. Sharquie, A. A. Noaimi and H. A. Al-Mudaris, “Melanocytes Transplant in Patients with Vitiligo Using Needling Micrografting Technique,” Thesis for Fellowship of Iraqi Board for Medical Specializations in Dermatology and Venereology, 2012.
 K. E. Sharquie, A. A. Noaimi and H. A. Al-Mudaris, “Direct Melanocytes Transplant from Normal Donor Area into Vitiliginous Recipient Area by Dermabrasion Technique,” Journal of Cosmetic, Dermatological Sciences and Application, Vol. 2, No. 4, 2012, pp. 288-293. doi:10.4236/jcdsa.2012.24055
 S. Sethi, B. B. Mahajan, R. R. Gupta and A. Ohri, “Comparative Evaluation of the Therapeutic Efficacy of Dermabrasion, Dermabrasion Combined with Topical 5% 5-Fluorouracil Cream, and Dermabrasion Combined with Topical Placentrex Gel in Localized Stable Vitiligo,” International Journal of Dermatology, Vol. 46, No. 8, 2007, pp. 875-879. doi:10.1111/j.1365-4632.2007.03226.x
 P. Redondo, A. G. Azcarate, L. Marques, M. G. Guzman, E. Andreu and F. Prosper, “Amniotic Membrane as a Scaffold for Melanocytes Transplantation in patients with Stable Vitiligo,” Dermatology Research and Practice, 2011, pp. 1-6. doi:10.1155/2011/532139
 O. T. Vázquez-Martínez, H. G. Matínez-Rodríguez, L. Velásquez-Arenas, D. Banos-González, R. Ortíz-López, G. Padilla-Rivas, O. Welsh and J. Ocampo-Candiani, “Treatment of Vitiligo with a Melanocytes-Keratiocyte Cell Suspension versus Dermabrasion Only: A Pilot Study with a 12 Month Follow Up,” Journal of Drugs in Dermatology, Vol. 10, No. 9, 2011, pp. 1032-1036.